 Amyloid Neuropathies, Familial
"Amyloid Neuropathies, Familial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inherited disorders of the peripheral nervous system associated with the deposition of AMYLOID in nerve tissue. The different clinical types based on symptoms correspond to the presence of a variety of mutations in several different proteins including transthyretin (PREALBUMIN); APOLIPOPROTEIN A-I; and GELSOLIN.
| Descriptor ID |
D028227
|
| MeSH Number(s) |
C10.574.500.050 C10.668.829.050.050 C16.320.400.050 C16.320.565.176.050 C18.452.648.176.050 C18.452.845.500.050.050 C18.452.845.500.075.050
|
| Concept/Terms |
Amyloid Neuropathies, Familial- Amyloid Neuropathies, Familial
- Amyloid Neuropathy, Familial
- Familial Amyloid Neuropathies
- Familial Amyloid Neuropathy
- Neuropathies, Familial Amyloid
- Neuropathy, Familial Amyloid
- Hereditary Neuropathic Amyloidosis
- Amyloidoses, Hereditary Neuropathic
- Amyloidosis, Hereditary Neuropathic
- Hereditary Neuropathic Amyloidoses
- Neuropathic Amyloidoses, Hereditary
- Neuropathic Amyloidosis, Hereditary
- Familial Amyloid Polyneuropathies
- Amyloid Polyneuropathies, Familial
- Amyloid Polyneuropathy, Familial
- Familial Amyloid Polyneuropathy
- Polyneuropathies, Familial Amyloid
- Polyneuropathy, Familial Amyloid
Amyloid Polyneuropathy, British Type- Amyloid Polyneuropathy, British Type
- Type III Familial Amyloid Polyneuropathy
- Familial Amyloid Polyneuropathy, Type III
- Iowa Type Amyloid Polyneuropathy
- Amyloid Polyneuropathy, Iowa Type
- British Type Amyloid Polyneuropathy
Familial Amyloid Neuropathy, Portuguese Type- Familial Amyloid Neuropathy, Portuguese Type
- Familial Amyloid Neuropathy, Andrade Type
- Familial Amyloid Polyneuropathy, Type I
- Familial Portuguese Polyneuritic Amyloidosis
- Wohlwill-Corino Andrade Syndrome
- Syndrome, Wohlwill-Corino Andrade
- Wohlwill Corino Andrade Syndrome
- Polyneuritic Amyloidosis, Portuguese
- Amyloidoses, Portuguese Polyneuritic
- Amyloidosis, Portuguese Polyneuritic
- Polyneuritic Amyloidoses, Portuguese
- Portuguese Polyneuritic Amyloidoses
- Portuguese Polyneuritic Amyloidosis
- Portuguese Type Familial Amyloid Neuropathy
- Type I Familial Amyloid Polyneuropathy
- Wohlwill-Andrade Syndrome
- Syndrome, Wohlwill-Andrade
- Wohlwill Andrade Syndrome
- Amyloid Neuropathy Type 1
- Neuropathic Amyloid Syndrome
- Amyloid Syndrome, Neuropathic
- Amyloid Syndromes, Neuropathic
- Neuropathic Amyloid Syndromes
- Syndrome, Neuropathic Amyloid
- Syndromes, Neuropathic Amyloid
Familial Amyloid Polyneuropathy, Type V- Familial Amyloid Polyneuropathy, Type V
- Finnish Type Familial Amyloid Neuropathy
- Type V Familial Amyloid Polyneuropathy
- Familial Amyloid Neuropathy, Finnish Type
Amyloid Polyneuropathy, Swiss Type- Amyloid Polyneuropathy, Swiss Type
- Swiss Type Amyloid Polyneuropathy
- Type II Familial Amyloid Polyneuropathy
- Familial Amyloid Polyneuropathy, Type II
|
Below are MeSH descriptors whose meaning is more general than "Amyloid Neuropathies, Familial".
- Diseases [C]
- Nervous System Diseases [C10]
- Neurodegenerative Diseases [C10.574]
- Heredodegenerative Disorders, Nervous System [C10.574.500]
- Amyloid Neuropathies, Familial [C10.574.500.050]
- Neuromuscular Diseases [C10.668]
- Peripheral Nervous System Diseases [C10.668.829]
- Amyloid Neuropathies [C10.668.829.050]
- Amyloid Neuropathies, Familial [C10.668.829.050.050]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Heredodegenerative Disorders, Nervous System [C16.320.400]
- Amyloid Neuropathies, Familial [C16.320.400.050]
- Metabolism, Inborn Errors [C16.320.565]
- Amyloidosis, Familial [C16.320.565.176]
- Amyloid Neuropathies, Familial [C16.320.565.176.050]
- Nutritional and Metabolic Diseases [C18]
- Metabolic Diseases [C18.452]
- Metabolism, Inborn Errors [C18.452.648]
- Amyloidosis, Familial [C18.452.648.176]
- Amyloid Neuropathies, Familial [C18.452.648.176.050]
- Proteostasis Deficiencies [C18.452.845]
- Amyloidosis [C18.452.845.500]
- Amyloid Neuropathies [C18.452.845.500.050]
- Amyloid Neuropathies, Familial [C18.452.845.500.050.050]
- Amyloidosis, Familial [C18.452.845.500.075]
- Amyloid Neuropathies, Familial [C18.452.845.500.075.050]
Below are MeSH descriptors whose meaning is more specific than "Amyloid Neuropathies, Familial".
This graph shows the total number of publications written about "Amyloid Neuropathies, Familial" by people in this website by year, and whether "Amyloid Neuropathies, Familial" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 | | 2006 | 1 | 0 | 1 | | 2019 | 1 | 0 | 1 | | 2020 | 2 | 0 | 2 | | 2022 | 2 | 0 | 2 | | 2023 | 1 | 0 | 1 | | 2024 | 2 | 0 | 2 | | 2025 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Amyloid Neuropathies, Familial" by people in Profiles.
-
Hussain Y, Malhotra S, Sperry BW, Shu F, Ananthasubramaniam K, Desai U, Egolum U, Fernandez J, Freimer M, Mauricio E, Quan D, Small R, Capocelli K, Roblin S, Bender S, Jay PY, Yureneva E, Zolty R. Impact of patisiran on polyneuropathy of hereditary transthyretin amyloidosis in patients with a V122I or T60A variant: a phase IV multicenter study. Ann Med. 2025 Dec; 57(1):2537347.
-
Maurer MS, Judge DP, Gillmore JD, Garcia-Pavia P, Masri A, Cappelli F, Alexander KM, Sarswat N, Grogan M, Ambardekar AV, Ducharme A, Poulsen SH, Lam K, Obici L, Soman P, Rao S, Tamby JF, Casta?o A, Fox JC, Adam B, Chepyala SR, Poland B, Sinha U, Fontana M. Early Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid Cardiomyopathy. J Am Coll Cardiol. 2025 May 27; 85(20):1911-1923.
-
Jacoby E, Quan D, Todd E, Shortt J, Smith H, Rafaels N, Crooks K. Prevalence of Pathogenic Transthyretin Gene Variants in the Rocky Mountain Region. Muscle Nerve. 2025 Feb; 71(2):252-256.
-
Judge DP, Gillmore JD, Alexander KM, Ambardekar AV, Cappelli F, Fontana M, Garc?a-Pav?a P, Grodin JL, Grogan M, Hanna M, Masri A, Nativi-Nicolau J, Obici L, Hvitfeldt Poulsen S, Sarswat N, Shah K, Soman P, Lystig T, Cao X, Wang K, Pecoraro ML, Tamby JF, Katz L, Sinha U, Fox JC, Maurer MS. Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM Trial. Circulation. 2025 Mar 04; 151(9):601-611.
-
Slaven S, Raymer DS, Mestroni L. The electrocardiographic signature of variant transthyretin amyloidosis. Int J Cardiol. 2024 03 01; 398:131442.
-
Quan D, Obici L, Berk JL, Ando Y, Aldinc E, White MT, Adams D. Impact of baseline polyneuropathy severity on patisiran treatment outcomes in the APOLLO trial. Amyloid. 2023 Mar; 30(1):49-58.
-
Parcha V, Malla G, Irvin MR, Armstrong ND, Judd SE, Lange LA, Maurer MS, Levitan EB, Goyal P, Arora G, Arora P. Association of Transthyretin Val122Ile Variant With Incident Heart Failure Among Black Individuals. JAMA. 2022 04 12; 327(14):1368-1378.
-
Adams D, Polydefkis M, Gonz?lez-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada L?pez IA, Dispenzieri A, Quan D, Concei??o IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Plant?-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study. Lancet Neurol. 2021 01; 20(1):49-59.
-
Vogt B, Chahin N, Wiszniewski W, Ragole T, Karam C. Screening for genetic mutations in patients with neuropathy without definite etiology is useful. J Neurol. 2020 Sep; 267(9):2648-2654.
-
González-Duarte A, Berk JL, Quan D, Mauermann ML, Schmidt HH, Polydefkis M, Waddington-Cruz M, Ueda M, Conceição IM, Kristen AV, Coelho T, Cauquil CA, Tard C, Merkel M, Aldinc E, Chen J, Sweetser MT, Wang JJ, Adams D. Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis. J Neurol. 2020 Mar; 267(3):703-712.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|